Joint Pain Injections Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Joint Pain Injections Market

1.1. Definition and Scope

1.1.1. Definition of Joint Pain Injections

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Joint Pain Injections Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Joint Pain Injections Market By Type 

1.2.3. Joint Pain Injections Market By Joint Type

1.2.4. Joint Pain Injections Market By Distribution Channel

1.2.5. Joint Pain Injections Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Type

2.2.1. Secondary Types

2.2.2. Primary Types

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Joint Pain Injections Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Joint Pain Injections Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2023

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023

4.2. R&D Status of Major Manufacturers in 2023

CHAPTER 5. Joint Pain Injections Market By Type

5.1. Introduction

5.2. Joint Pain Injections Revenue By Type

5.2.1. Joint Pain Injections Revenue (USD Million) and Forecast, By Type, 2020-2032

5.2.2. Hyaluronic Acid Injections

5.2.2.1. Hyaluronic Acid Injections Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Corticosteroid Injections

5.2.3.1. Corticosteroid Injections Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Interleukin Inhibitors

5.2.4.1. Interleukin Inhibitors Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5. Platelet-rich Plasma Injections

5.2.5.1. Platelet-rich Plasma Injections Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.6. Other (Steroid Joint Injections, Placental tissue matrix (PTM) Injections, etc.)

5.2.6.1. Other (Steroid Joint Injections, Placental tissue matrix (PTM) Injections, etc.) Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Joint Pain Injections Market By Joint Type

6.1. Introduction

6.2. Joint Pain Injections Revenue By Joint Type

6.2.1. Joint Pain Injections Revenue (USD Million) and Forecast, By Joint Type, 2020-2032

6.2.2. Knee and Ankle

6.2.2.1. Knee and Ankle Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Shoulder and Elbow

6.2.3.1. Shoulder and Elbow Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.4. Hip Joint

6.2.4.1. Hip Joint Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.5. Hand and Wrist

6.2.5.1. Hand and Wrist Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.6. Facet Joints of the Spine

6.2.6.1. Facet Joints of the Spine Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. Joint Pain Injections Market By Distribution Channel

7.1. Introduction

7.2. Joint Pain Injections Revenue By Distribution Channel

7.2.1. Joint Pain Injections Revenue (USD Million) and Forecast, By Distribution Channel, 2020-2032

7.2.2. Hospital Pharmacies

7.2.2.1. Hospital Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Online Pharmacies

7.2.3.1. Online Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Retail Pharmacies

7.2.4.1. Retail Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Joint Pain Injections Market By Country 

8.1. North America Joint Pain Injections Market Overview

8.2. U.S.

8.2.1. U.S. Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

8.2.2. U.S. Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

8.2.3. U.S. Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

8.3. Canada

8.3.1. Canada Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

8.3.2. Canada Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

8.3.3. Canada Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Joint Pain Injections Market By Country

9.1. Europe Joint Pain Injections Market Overview

9.2. U.K.

9.2.1. U.K. Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

9.2.2. U.K. Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

9.2.3. U.K. Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.3. Germany

9.3.1. Germany Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

9.3.2. Germany Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

9.3.3. Germany Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.4. France

9.4.1. France Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

9.4.2. France Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

9.4.3. France Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.5. Spain

9.5.1. Spain Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

9.5.2. Spain Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

9.5.3. Spain Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

9.6.2. Rest of Europe Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

9.6.3. Rest of Europe Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Joint Pain Injections Market By Country

10.1. Asia Pacific Joint Pain Injections Market Overview

10.2. China

10.2.1. China Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

10.2.2. China Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

10.2.3. China Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

10.3. Japan

10.3.1. Japan Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

10.3.2. Japan Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

10.3.3. Japan Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

10.4. India

10.4.1. India Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

10.4.2. India Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

10.4.3. India Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

10.5. Australia

10.5.1. Australia Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

10.5.2. Australia Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

10.5.3. Australia Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

10.6. South Korea

10.6.1. South Korea Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

10.6.2. South Korea Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

10.6.3. South Korea Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

10.7.2. Rest of Asia-Pacific Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

10.7.3. Rest of Asia-Pacific Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Joint Pain Injections Market By Country

11.1. Latin America Joint Pain Injections Market Overview

11.2. Brazil

11.2.1. Brazil Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

11.2.2. Brazil Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

11.2.3. Brazil Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

11.3. Mexico

11.3.1. Mexico Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

11.3.2. Mexico Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

11.3.3. Mexico Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

11.4.2. Rest of Latin America Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

11.4.3. Rest of Latin America Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Joint Pain Injections Market By Country 

12.1. Middle East & Africa Joint Pain Injections Market Overview

12.2. GCC

12.2.1. GCC Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

12.2.2. GCC Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

12.2.3. GCC Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

12.3. South Africa

12.3.1. South Africa Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

12.3.2. South Africa Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

12.3.3. South Africa Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032

12.4.2. Rest of Middle East & Africa Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032

12.4.3. Rest of Middle East & Africa Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Joint Pain Injections Market

13.1. Joint Pain Injections Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Joint Pain Injections Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Pfizer

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Million), 2023

14.1.3.2. Pfizer 2023 Joint Pain Injections Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Anika Therapeutics

14.3. Sanofi

14.4. Zimmer Biomet Holdings

14.5. Bioventus

14.6. Flexion Therapeutics

14.7. SEIKAGAKU CORPORATION

14.8. Ferring

14.9. Chugai Pharmaceutical

14.10. Allergan